BGI Genomics: On March 13, net short selling of 700 shares, cumulative net short selling of 3,500 shares over 3 consecutive days

Securities Star News: On March 13, Huada Gene (300676) had a margin buy-in of 16.6295 million yuan, a margin repayment of 16.4298 million yuan, with a net margin buy of 1.997 million yuan. The margin balance stands at 985 million yuan.

Regarding securities lending, on the same day, 700 shares were sold short, with no shares repaid, resulting in a net short sale of 700 shares. The remaining securities lending balance is 191,900 shares. Over the past three trading days, there has been a continuous net sale totaling 3,500 shares.

The total margin and securities lending balance is 994 million yuan, up 0.01% from yesterday.

Quick Tip

Margin Trading and Securities Lending: An increase in margin balance indicates strengthening bullish market sentiment, while a decrease suggests a wait-and-see or bearish sentiment. Similarly, an increase in securities lending balance indicates growing bearish sentiment, and a decrease indicates a more cautious or bullish outlook. It’s important to note that due to the leverage effect of margin trading and securities lending, they can be a double-edged sword for investors—like a magnifying glass. Profits can grow exponentially in favorable conditions, but losses can also be amplified significantly.

The above content is compiled from publicly available information by Securities Star, generated by AI algorithm (Wang Xin Suan Bei 310104345710301240019), and does not constitute investment advice.